POSSIBLE STRATEGIES FOR IMPLEMENTATION OF THE WHO PROGRAM ON THE ELIMINATION OF HEPATITIS C IN UKRAINE BY 2030
Journal Title: Гепатологія - Year 2017, Vol 38, Issue 4
Abstract
Chronic infection with hepatitis C virus (HCV) is a leading indicator for liver disease. Morbidity and mortality attributable to chronic HCV infection are increasing as the infected population ages. New treatment options are becoming available, and there is a need to characterize the epidemiology and disease burden of HCV. Model has been used to forecast the progression of liver disease and to estimate the total burden and changes in HCV sequelae over time with the natural history and under the infl uence of treatment. Model was developed to quantify and characterize the viremic population, as well as the number of new infections and HCV related deaths from 2000 to 2030. Possible strategies for the implementation of the WHO program should be presented for the elimination of hepatitis C in Ukraine by 2030. Increasing levels of diagnosis and treatment, in combination with improved treatment effi cacy, were critical for achieving substantial reductions in disease burden. In Ukraine, the number of annually treated population had to increase several fold to achieve the largest reductions in HCV-related morbidity and mortality. To achieve the goals of the WHO elimination program, it is necessary to treat at least 50% of the population with hepatitis C in Ukraine. Th is suggests that increased capacity for screening and treatment will be critical for Ukraine.
Authors and Affiliations
I Zaytsev, V Potii
Keywords
Related Articles
- EP ID EP289109
- DOI -
- Views 92
- Downloads 0
Всеукраїнська науково-практична конференція «Сучасні діагностичні, лікувальні і профілактичні технології у практиці інфекціоніста» та пленум ГО «Всеукраїнська асоціація інфекціоністів»
5-6 жовтня 2018 року в м. Чернівці відбулась Всеукраїнська науково-практична конференція на тему «Сучасні діагностичні, лікувальні та профілактичні технології у практиці інфекціоніста» та пленум ГО «Всеукраїнська асоціац...
CLINICAL FEATURES OF HCV-ASSOCIATED EXTRAHEPATIC MANIFESTATIONS OF HEMATOLOGICAL NATURE
In this article, 6 cases of extrahepatic manifestations of chronic hepatitis C of hematological nature, which were diagnosed simultaneously with identifi cation of chronic hepatitis C and combined w...
AGE AND GENDER PECULIARITIES OF BIOCHEMICAL INDICATORS, LIPID AND CYTOKIN BLOOD PROFILES IN NONVIRAL CHRONIC HEPATITIS PATIENTS
Currently, an increase in the incidence of nonviral chronic hepatitis is observed in Ukraine and worldwide. Pro and anti-infl ammatory cytokines play an active role in the pathogenesis of chronic hepatitis, acting as m...
CLINICAL LABORATORY AND IMMUNOLOGICAL FEATURES OF CHRONIC HEPATITIS C IN PATIENTS UNDERGOING ANTIVIRAL THERAPY WITH PEGYLATED INTERFERON
Studying the course of chronic viral hepatitis C, polymorphism of clinical signs, deviation in clinical and biochemical blood analyses and specifi c changes in indices during antiviral therapy have been established. Data...
ПАРОКСИЗМАЛЬНА ХОЛОДОВА ГЕМОГЛОБІНУРІЯ – ЩЕ ОДИН АСПЕКТ ДИФЕРЕНЦІАЛЬНОЇ ДІАГНОСТИКИ ЖОВТЯНИЦЬ
The article presents brief information about a rare form of autoimmune hemolytic anemia – paroxysmal hemoglobinuria and clinical example of a patient with this disease.The method of differential and diagnostic search in...